Delivery Order SPE2DX15D3404-SPE2DX24F1BUG
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Enbrel 25 mg/0.5 mL syringe, with a firm fixed price and a ceiling value of $4,178.14. The contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Enbrel, a medication used to treat autoimmune conditions, at a firm fixed price of $40,084.52. The contract has an ultimate completion date of April 29, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,339.86 firm fixed-price contract is for the supply of ENBREL 25 MG/0.5 ML VIAL 0.5ML, a specialty medication. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 mg/mL syringes, a medication used to treat certain autoimmune diseases. The contract has a ceiling value of $6,981.73 and a performance period ending on May 2, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $40,727.64 and a completion date of May 19, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,301.10, is for the provision of ENBREL 50 MG/ML syringes, a medication used to treat various autoimmune disorders. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract, valued at $57,321.41, to Amerisourcebergen Drug Corporation's Corporate Office division. This contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 22, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 50 mg/mL ENBREL medication and has a ceiling value of $9,253.56. It is a firm fixed-price contract with a completion date of May 21, 2025. The contract is not set-aside for any specific business type. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Enbrel 50 mg/ml syringes. The contract has a ceiling value of $16,608.56 and a performance period running through August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- SPE2DX15D3404Indefinite Delivery Contract
- SPE2DX15D3404-SPE2DX24F1BUGDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Enbrel 25 mg/0.5 ml vials, a biologic medication used to treat various autoimmune conditions. The fixed-price contract has a ceiling value of $7,528.95 and an ultimate completion date of May 17, 2024. Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. This contract was awarded on a full and open competition basis without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/16/24 |